Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5183119
Max Phase: Preclinical
Molecular Formula: C45H42ClN9O6S
Molecular Weight: 872.41
Associated Items:
ID: ALA5183119
Max Phase: Preclinical
Molecular Formula: C45H42ClN9O6S
Molecular Weight: 872.41
Associated Items:
Canonical SMILES: Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)Nc1ccc3c(c1)C(=O)N(CCCCCNc1cccc4c1C(=O)N(C1CCC(=O)NC1=O)C4=O)C3)c1nnc(C)n1-2
Standard InChI: InChI=1S/C45H42ClN9O6S/c1-23-24(2)62-45-37(23)39(26-10-13-28(46)14-11-26)49-33(40-52-51-25(3)54(40)45)21-36(57)48-29-15-12-27-22-53(42(59)31(27)20-29)19-6-4-5-18-47-32-9-7-8-30-38(32)44(61)55(43(30)60)34-16-17-35(56)50-41(34)58/h7-15,20,33-34,47H,4-6,16-19,21-22H2,1-3H3,(H,48,57)(H,50,56,58)/t33-,34?/m0/s1
Standard InChI Key: YFQXJXAHQXFHRD-CDRRMRQFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 872.41 | Molecular Weight (Monoisotopic): 871.2667 | AlogP: 6.47 | #Rotatable Bonds: 12 |
Polar Surface Area: 188.06 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.59 | CX Basic pKa: 4.12 | CX LogP: 5.53 | CX LogD: 5.53 |
Aromatic Rings: 5 | Heavy Atoms: 62 | QED Weighted: 0.09 | Np Likeness Score: -0.98 |
1. Guo L, Zhou Y, Nie X, Zhang Z, Zhang Z, Li C, Wang T, Tang W.. (2022) A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions., 236 [PMID:35397401] [10.1016/j.ejmech.2022.114317] |
Source(1):